<DOC>
	<DOCNO>NCT00471588</DOCNO>
	<brief_summary>3 group subject ( healthy control , OCD subject stimulant-dependent subject ) receive pramipexole ( 1.5 mg , single dose ) , amisulpride ( 400 mg , single dose ) placebo cross-over , double-blind , placebo-controlled design . Effects compulsive behaviour assess use fMRI cognitive testing . Assess biomarkers include cardiovascular response plasma level . All group study 3 separate occasion follow screening , least week intervene consecutive assessment . The procedure adopt study assessment identical occasion .</brief_summary>
	<brief_title>Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors</brief_title>
	<detailed_description />
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Male female , 18 55 year age ; group match either handedness . Participants must ability comprehend key component consent form provide inform consent . Participants must lead write ( English ) level sufficient complete study related assessment . Assessment psychiatrist psychologist , include facetoface evaluation individual use DSMVI diagnosis . No history neurological disorder , head/brain injury , hepatitis , visual impairment . No MRI contraindication ( metal body , claustrophobia ) able provide blood sample ( venous accessibility , especially relevant drug user ) . Patients obsessivecompulsive disorder minimum 2year history compulsive behaviour satisfy DSMIVTR criterion OCD . Participants chronic stimulant use minimum 2year history dependence class A stimulant , age drug abuse onset 20 year , satisfy DSMIVTR criterion dependence stimulant drug . Control volunteer good mental physical health . A personal history psychiatric neurological disorder , define DSMIV ( except OCD patient OCD substance dependence drug user ) A history presence alcohol / substance abuse dependence ( nicotine ) , define DSMIVTR ( except drug dependence group ) . A BDIII total score great 14 lead exclusion study . Treatment methadone buprenorphine may interfere experimental task , therefore , lead exclusion study . Participants laboratory abnormality investigator 's judgement consider clinically significant could potentially affect subject safety study outcome . History clinically significant current renal dysfunction . Clinically significant abnormality hematology , blood chemistry , MRI , urinalysis physical examination resolve baseline visit . Impaired liver function baseline history liver dysfunction . Female participant pregnant currently breastfeed . Any serious medical disorder condition would Investigator 's opinion , preclude administration study medication history clinically significant hepatic , cardiac , renal , neurologic , cerebrovascular , metabolic pulmonary disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Dopamine</keyword>
	<keyword>OCD</keyword>
	<keyword>MRI</keyword>
	<keyword>stimulant user</keyword>
</DOC>